From: Study of HOTAIR LncRNA in AML patients in context to FLT3-ITD and NPM1 mutations status
Number | Months | Significance | ||
---|---|---|---|---|
All | 18 | |||
Gender | ||||
Male | 8 | 7 (4.9–9) | 0.912 | |
Female | 10 | 9 (2.5–15) | ||
Age | ||||
< 50 | 16 | 9 (6.5–11.5) | 0.064 | |
≥ 50 | 2 | 5 (6.4–11.4) | ||
TLC | ||||
< 50 | 15 | 11 (6.7–15.3) | 0.423 | |
≥ 50 | 3 | 9 (6.4–11.5) | ||
HB | ||||
< 8 | 3 | 9 | 0.875 | |
≥ 8 | 15 | 9 (4.3–13.6) | ||
PLT | ||||
< 50 | 11 | 9 (7.3–10.7) | 0.552 | |
≥ 50 | 7 | 11 (1.8–20) | ||
Expression | ||||
Low | 8 | 7 (4.5–9.5) | 0.04 | |
High | 19 | 11 | ||
Blast | ||||
< 50 | 5 | 9 (5.7–12.2) | 0.421 | |
≥ 50 | 13 | 9 (6.4–11.5) | ||
Wild-FLT3 | Wild-NPM1 | 8 | 9 | 0.194 |
Mutant-NPM1 | 1 | 9 | ||
FLT3-ITD | Wild-NPM1 | 6 | 12 | |
Mutant NPM1 | 3 | 7 |